Henry E. Schea
President at Genopoietic SA
Henry E. Schea active positions
| Companies | Position | Start | End |
|---|---|---|---|
Genopoietic SA
 Genopoietic SA BiotechnologyHealth Technology Part of AVAX Technologies, Inc., Genopoietic SA is a French company that researches and develops cell and gene therapy for cancer, autoimmune diseases, and orthopedics. The company is based in Paris, France. Genopoietic was acquired by AVAX Technologies, Inc. on August 24, 2000 for $198.62 million. | President | 2011-10-20 | - |
Career history of Henry E. Schea
Former positions of Henry E. Schea
| Companies | Position | Start | End |
|---|---|---|---|
| AVAX TECHNOLOGIES, INC. | General Counsel | 2010-01-03 | 2016-03-31 |
Training of Henry E. Schea
| University of Massachusetts | Undergraduate Degree |
Statistics
International
| United States | 3 |
| France | 2 |
Operational
| General Counsel | 1 |
| President | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| AVAX TECHNOLOGIES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Genopoietic SA
Genopoietic SA BiotechnologyHealth Technology Part of AVAX Technologies, Inc., Genopoietic SA is a French company that researches and develops cell and gene therapy for cancer, autoimmune diseases, and orthopedics. The company is based in Paris, France. Genopoietic was acquired by AVAX Technologies, Inc. on August 24, 2000 for $198.62 million. | Health Technology |
- Stock Market
- Insiders
- Henry E. Schea
- Experience
